| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 21 | 2022 | 700 | 5.160 |
Why?
|
| Inflammasomes | 7 | 2021 | 169 | 2.980 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 15 | 2019 | 243 | 2.360 |
Why?
|
| Myocytes, Cardiac | 12 | 2021 | 663 | 1.470 |
Why?
|
| Tankyrases | 3 | 2019 | 5 | 1.320 |
Why?
|
| Sarcoplasmic Reticulum | 9 | 2019 | 199 | 1.240 |
Why?
|
| Calcium | 11 | 2021 | 1148 | 1.190 |
Why?
|
| Calcium Signaling | 9 | 2021 | 255 | 1.080 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 4 | 2021 | 128 | 1.060 |
Why?
|
| Heart Atria | 6 | 2021 | 339 | 1.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2019 | 65 | 1.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 377 | 0.990 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 7 | 2018 | 174 | 0.920 |
Why?
|
| Lung Neoplasms | 5 | 2021 | 1783 | 0.910 |
Why?
|
| Tachycardia, Ventricular | 5 | 2022 | 207 | 0.880 |
Why?
|
| Organogenesis | 1 | 2023 | 84 | 0.770 |
Why?
|
| Yolk Sac | 1 | 2022 | 20 | 0.760 |
Why?
|
| Heart Rate | 4 | 2021 | 601 | 0.750 |
Why?
|
| Vascular Remodeling | 1 | 2022 | 54 | 0.750 |
Why?
|
| Down-Regulation | 5 | 2019 | 718 | 0.740 |
Why?
|
| Animals | 42 | 2023 | 36520 | 0.720 |
Why?
|
| Radiation Tolerance | 2 | 2018 | 67 | 0.710 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2019 | 182 | 0.700 |
Why?
|
| Mindfulness | 1 | 2021 | 26 | 0.690 |
Why?
|
| Embryo Implantation | 1 | 2023 | 235 | 0.690 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 127 | 0.680 |
Why?
|
| Mice | 29 | 2023 | 19044 | 0.660 |
Why?
|
| Proteostasis | 1 | 2020 | 38 | 0.650 |
Why?
|
| Behcet Syndrome | 1 | 2019 | 17 | 0.630 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 2177 | 0.610 |
Why?
|
| Signal Transduction | 9 | 2021 | 4936 | 0.610 |
Why?
|
| MicroRNAs | 3 | 2015 | 949 | 0.610 |
Why?
|
| Disease Models, Animal | 16 | 2021 | 4802 | 0.610 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 608 | 0.610 |
Why?
|
| Psychology, Adolescent | 1 | 2019 | 35 | 0.610 |
Why?
|
| Histone Demethylases | 2 | 2016 | 43 | 0.600 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 36 | 0.600 |
Why?
|
| Prostatic Neoplasms | 3 | 2018 | 1626 | 0.600 |
Why?
|
| Microtubules | 2 | 2018 | 133 | 0.590 |
Why?
|
| Epigenetic Repression | 1 | 2018 | 4 | 0.590 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 127 | 0.580 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2018 | 38 | 0.580 |
Why?
|
| Pyrimidinones | 1 | 2018 | 59 | 0.570 |
Why?
|
| Anger | 1 | 2018 | 30 | 0.570 |
Why?
|
| Cadherins | 2 | 2018 | 186 | 0.570 |
Why?
|
| Zebrafish Proteins | 2 | 2018 | 130 | 0.570 |
Why?
|
| DNA Repair Enzymes | 1 | 2017 | 48 | 0.550 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 138 | 0.550 |
Why?
|
| Pyridones | 1 | 2018 | 130 | 0.550 |
Why?
|
| Personal Autonomy | 1 | 2019 | 202 | 0.540 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 179 | 0.540 |
Why?
|
| Peroxisomes | 1 | 2017 | 42 | 0.540 |
Why?
|
| Mice, Knockout | 13 | 2023 | 4012 | 0.540 |
Why?
|
| Myocardium | 7 | 2014 | 1041 | 0.530 |
Why?
|
| Parent-Child Relations | 1 | 2019 | 254 | 0.530 |
Why?
|
| Tetracaine | 1 | 2016 | 12 | 0.520 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 2137 | 0.520 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 207 | 0.520 |
Why?
|
| Inflammation | 4 | 2021 | 1595 | 0.510 |
Why?
|
| Cell Movement | 3 | 2018 | 920 | 0.510 |
Why?
|
| Hyperuricemia | 1 | 2016 | 41 | 0.510 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 1167 | 0.510 |
Why?
|
| Zebrafish | 2 | 2018 | 421 | 0.500 |
Why?
|
| Humans | 47 | 2023 | 134145 | 0.500 |
Why?
|
| Gene Knockdown Techniques | 4 | 2019 | 399 | 0.500 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2022 | 228 | 0.500 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 1098 | 0.500 |
Why?
|
| Uric Acid | 1 | 2016 | 109 | 0.500 |
Why?
|
| Channelopathies | 1 | 2016 | 13 | 0.490 |
Why?
|
| Proteomics | 5 | 2021 | 603 | 0.490 |
Why?
|
| Mutation | 9 | 2019 | 6341 | 0.470 |
Why?
|
| Learning | 1 | 2019 | 375 | 0.470 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 3800 | 0.460 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1853 | 0.460 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 225 | 0.460 |
Why?
|
| RNA, Messenger | 3 | 2018 | 2915 | 0.450 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 469 | 0.440 |
Why?
|
| Cytoskeleton | 1 | 2015 | 173 | 0.440 |
Why?
|
| Epigenomics | 1 | 2015 | 196 | 0.440 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2014 | 13 | 0.440 |
Why?
|
| Energy Metabolism | 1 | 2019 | 814 | 0.440 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 497 | 0.430 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 823 | 0.430 |
Why?
|
| Electric Stimulation | 2 | 2012 | 290 | 0.410 |
Why?
|
| Actins | 1 | 2015 | 353 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2022 | 478 | 0.400 |
Why?
|
| Gene Expression | 1 | 2017 | 1622 | 0.400 |
Why?
|
| Decision Making | 1 | 2018 | 701 | 0.390 |
Why?
|
| Histones | 1 | 2016 | 572 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 645 | 0.390 |
Why?
|
| Salivary Glands, Minor | 1 | 2011 | 11 | 0.380 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2011 | 34 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 385 | 0.360 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2011 | 71 | 0.360 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2011 | 67 | 0.360 |
Why?
|
| Transcription Factors | 3 | 2018 | 2734 | 0.360 |
Why?
|
| Heart Failure | 6 | 2019 | 2439 | 0.350 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 2771 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 4882 | 0.330 |
Why?
|
| Phosphoproteins | 3 | 2019 | 458 | 0.330 |
Why?
|
| DNA Methylation | 1 | 2016 | 1148 | 0.310 |
Why?
|
| Obesity | 1 | 2021 | 2448 | 0.310 |
Why?
|
| Action Potentials | 4 | 2021 | 523 | 0.290 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2010 | 267 | 0.280 |
Why?
|
| Mice, Nude | 3 | 2019 | 780 | 0.280 |
Why?
|
| Proteome | 2 | 2020 | 282 | 0.280 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 2538 | 0.270 |
Why?
|
| Proteolysis | 2 | 2020 | 199 | 0.270 |
Why?
|
| Cell Proliferation | 4 | 2019 | 2562 | 0.260 |
Why?
|
| Protein Phosphatase 1 | 2 | 2019 | 55 | 0.260 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2016 | 39 | 0.250 |
Why?
|
| Carcinogenesis | 2 | 2019 | 363 | 0.240 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 1013 | 0.240 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2018 | 68 | 0.230 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 337 | 0.220 |
Why?
|
| Sulfones | 3 | 2019 | 75 | 0.220 |
Why?
|
| Neoplasms | 1 | 2019 | 3035 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 676 | 0.220 |
Why?
|
| Transfection | 2 | 2016 | 1098 | 0.210 |
Why?
|
| Female | 20 | 2021 | 72004 | 0.210 |
Why?
|
| Male | 17 | 2021 | 66171 | 0.210 |
Why?
|
| Arteries | 2 | 2022 | 231 | 0.210 |
Why?
|
| Prognosis | 4 | 2018 | 5084 | 0.210 |
Why?
|
| Phosphorylation | 8 | 2019 | 1713 | 0.200 |
Why?
|
| Heart Conduction System | 2 | 2014 | 149 | 0.200 |
Why?
|
| Cardiomyopathies | 2 | 2022 | 519 | 0.190 |
Why?
|
| Up-Regulation | 5 | 2020 | 914 | 0.190 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 96 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2021 | 3677 | 0.190 |
Why?
|
| HEK293 Cells | 4 | 2019 | 824 | 0.190 |
Why?
|
| Gene Knock-In Techniques | 3 | 2019 | 127 | 0.190 |
Why?
|
| Fibrosis | 4 | 2019 | 461 | 0.190 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2022 | 99 | 0.190 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 9 | 0.180 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 18 | 0.180 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 233 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 628 | 0.180 |
Why?
|
| Triazoles | 2 | 2019 | 142 | 0.180 |
Why?
|
| Ventricular Remodeling | 4 | 2012 | 191 | 0.170 |
Why?
|
| Dependovirus | 2 | 2019 | 152 | 0.170 |
Why?
|
| Universities | 1 | 2021 | 128 | 0.170 |
Why?
|
| Aging | 3 | 2022 | 1309 | 0.170 |
Why?
|
| HeLa Cells | 2 | 2019 | 838 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 399 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2020 | 393 | 0.160 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2019 | 11 | 0.160 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 1761 | 0.160 |
Why?
|
| para-Aminobenzoates | 1 | 2019 | 5 | 0.160 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 467 | 0.160 |
Why?
|
| Silk | 1 | 2019 | 4 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 168 | 0.160 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 1721 | 0.160 |
Why?
|
| Armadillo Domain Proteins | 1 | 2019 | 9 | 0.150 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 16 | 0.150 |
Why?
|
| Phosphoramide Mustards | 1 | 2018 | 3 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2019 | 1621 | 0.150 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 52 | 0.150 |
Why?
|
| Cross-Cultural Comparison | 1 | 2019 | 59 | 0.150 |
Why?
|
| Neutrophils | 2 | 2019 | 401 | 0.150 |
Why?
|
| Students | 1 | 2021 | 261 | 0.150 |
Why?
|
| Adolescent Development | 1 | 2019 | 34 | 0.150 |
Why?
|
| Mothers | 1 | 2021 | 372 | 0.150 |
Why?
|
| Parenting | 2 | 2021 | 348 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 3 | 2018 | 300 | 0.150 |
Why?
|
| Aurora Kinase B | 1 | 2018 | 8 | 0.150 |
Why?
|
| Nitroimidazoles | 1 | 2018 | 44 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2022 | 539 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 532 | 0.150 |
Why?
|
| Immunohistochemistry | 4 | 2017 | 1764 | 0.140 |
Why?
|
| In Situ Hybridization | 2 | 2017 | 485 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 2669 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2019 | 155 | 0.140 |
Why?
|
| RNA Interference | 2 | 2018 | 548 | 0.140 |
Why?
|
| Genetic Vectors | 2 | 2019 | 967 | 0.140 |
Why?
|
| China | 1 | 2019 | 296 | 0.140 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2017 | 10 | 0.140 |
Why?
|
| Wernicke Area | 1 | 2017 | 2 | 0.140 |
Why?
|
| Atrial Remodeling | 1 | 2018 | 14 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 223 | 0.140 |
Why?
|
| Embryo, Nonmammalian | 1 | 2018 | 151 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 320 | 0.140 |
Why?
|
| Heart Arrest | 1 | 2022 | 375 | 0.140 |
Why?
|
| Educational Status | 1 | 2019 | 298 | 0.140 |
Why?
|
| Phenotype | 4 | 2023 | 4605 | 0.140 |
Why?
|
| Protein Binding | 3 | 2016 | 1860 | 0.140 |
Why?
|
| Time Factors | 4 | 2016 | 6592 | 0.140 |
Why?
|
| Age Factors | 3 | 2014 | 2997 | 0.130 |
Why?
|
| Psychometrics | 1 | 2021 | 690 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 362 | 0.130 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 183 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 3056 | 0.130 |
Why?
|
| Thiazepines | 1 | 2016 | 8 | 0.130 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 99 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 494 | 0.130 |
Why?
|
| Speech | 1 | 2017 | 78 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1087 | 0.130 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2016 | 6 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2018 | 224 | 0.130 |
Why?
|
| Binding Sites | 2 | 2016 | 1386 | 0.130 |
Why?
|
| Social Support | 1 | 2019 | 389 | 0.130 |
Why?
|
| Gene Editing | 1 | 2018 | 213 | 0.120 |
Why?
|
| Aged | 7 | 2021 | 21789 | 0.120 |
Why?
|
| Acetylation | 1 | 2016 | 195 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 149 | 0.120 |
Why?
|
| Language | 1 | 2017 | 222 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 296 | 0.120 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 90 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2016 | 259 | 0.120 |
Why?
|
| Cytokines | 3 | 2018 | 1397 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2019 | 3180 | 0.120 |
Why?
|
| Exocytosis | 1 | 2015 | 66 | 0.120 |
Why?
|
| Homeostasis | 1 | 2019 | 751 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 739 | 0.120 |
Why?
|
| Autophagy | 1 | 2018 | 429 | 0.110 |
Why?
|
| Optical Imaging | 1 | 2015 | 74 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1510 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2016 | 874 | 0.110 |
Why?
|
| DNA Primers | 1 | 2015 | 672 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2015 | 239 | 0.110 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2017 | 285 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 299 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 367 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2015 | 226 | 0.110 |
Why?
|
| COUP Transcription Factor I | 1 | 2013 | 91 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1312 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2018 | 738 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 1486 | 0.100 |
Why?
|
| Ear, Inner | 1 | 2013 | 50 | 0.100 |
Why?
|
| beta Catenin | 1 | 2015 | 232 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1391 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 510 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 804 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2018 | 750 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 546 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 745 | 0.100 |
Why?
|
| Cardiomegaly | 2 | 2012 | 138 | 0.100 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 2091 | 0.100 |
Why?
|
| Cell Line | 1 | 2018 | 2863 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 399 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1147 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1735 | 0.100 |
Why?
|
| Adolescent | 4 | 2019 | 20643 | 0.100 |
Why?
|
| Apoptosis | 1 | 2019 | 1945 | 0.100 |
Why?
|
| Social Class | 1 | 2014 | 210 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 390 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2014 | 651 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 589 | 0.100 |
Why?
|
| Ovary | 1 | 2015 | 390 | 0.100 |
Why?
|
| Disease Progression | 3 | 2014 | 2265 | 0.090 |
Why?
|
| Middle Aged | 8 | 2018 | 29395 | 0.090 |
Why?
|
| Biomarkers | 3 | 2021 | 3431 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 787 | 0.090 |
Why?
|
| Eye Neoplasms | 1 | 2011 | 53 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 46 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2011 | 174 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 1070 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 400 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2017 | 13098 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 1205 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1357 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 4006 | 0.090 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 262 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2011 | 116 | 0.080 |
Why?
|
| Electrocardiography | 3 | 2010 | 1006 | 0.080 |
Why?
|
| DNA Repair | 1 | 2014 | 638 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2010 | 59 | 0.080 |
Why?
|
| Mice, Inbred mdx | 3 | 2018 | 46 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3758 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 485 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1771 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 172 | 0.080 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 36 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2020 | 315 | 0.080 |
Why?
|
| Genomics | 1 | 2017 | 1678 | 0.080 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2008 | 3 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2010 | 918 | 0.070 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2020 | 42 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 74 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2008 | 143 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1387 | 0.070 |
Why?
|
| DNA | 1 | 2013 | 1684 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2008 | 114 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1922 | 0.070 |
Why?
|
| Isoproterenol | 2 | 2022 | 110 | 0.070 |
Why?
|
| Collagen | 1 | 2008 | 330 | 0.070 |
Why?
|
| Encephalomyocarditis virus | 1 | 2006 | 8 | 0.070 |
Why?
|
| Cardiovirus Infections | 1 | 2006 | 7 | 0.070 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2006 | 22 | 0.060 |
Why?
|
| Heat-Shock Response | 1 | 2006 | 36 | 0.060 |
Why?
|
| Wound Healing | 1 | 2010 | 489 | 0.060 |
Why?
|
| Serine | 2 | 2019 | 185 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 468 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 719 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 907 | 0.050 |
Why?
|
| Risk Factors | 2 | 2016 | 11184 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2012 | 1138 | 0.050 |
Why?
|
| Young Adult | 4 | 2021 | 9960 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2006 | 415 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2015 | 289 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 58 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 127 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 44 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 72 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2019 | 838 | 0.040 |
Why?
|
| Hypertension | 1 | 2010 | 1407 | 0.040 |
Why?
|
| Fetal Proteins | 1 | 2020 | 13 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2021 | 246 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2014 | 400 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2170 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 2012 | 270 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 235 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 53 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 30 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6610 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 35 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 103 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2009 | 121 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 104 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 211 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 167 | 0.040 |
Why?
|
| Alopecia | 1 | 2018 | 41 | 0.040 |
Why?
|
| Leukopenia | 1 | 2018 | 48 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2019 | 55 | 0.040 |
Why?
|
| NADPH Oxidase 2 | 1 | 2018 | 41 | 0.040 |
Why?
|
| Mental Health | 1 | 2021 | 374 | 0.040 |
Why?
|
| Spindle Apparatus | 1 | 2018 | 50 | 0.040 |
Why?
|
| Adult | 5 | 2018 | 31944 | 0.040 |
Why?
|
| Incidence | 2 | 2017 | 3421 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 673 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2019 | 399 | 0.030 |
Why?
|
| Chemokines | 2 | 2008 | 138 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 798 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2017 | 93 | 0.030 |
Why?
|
| Mitosis | 1 | 2018 | 205 | 0.030 |
Why?
|
| Fatigue | 1 | 2018 | 202 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 401 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 3714 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 237 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 196 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2018 | 289 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 258 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 331 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 444 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 720 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2021 | 603 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 972 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 406 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 738 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 427 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 333 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 488 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 855 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 45 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 405 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 174 | 0.030 |
Why?
|
| Dishevelled Proteins | 1 | 2015 | 45 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1538 | 0.030 |
Why?
|
| Child | 3 | 2022 | 25911 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1183 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1434 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 559 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 132 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 276 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2793 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 399 | 0.030 |
Why?
|
| Macrophages | 2 | 2008 | 710 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 120 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 897 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 207 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 3508 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 72 | 0.030 |
Why?
|
| Echocardiography | 2 | 2010 | 1132 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3867 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 504 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 115 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2012 | 28 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 120 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 416 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2018 | 874 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2013 | 173 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 1908 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 41 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2015 | 691 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 446 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 843 | 0.020 |
Why?
|
| Sarcolemma | 1 | 2010 | 23 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2010 | 42 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 51 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 217 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 920 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2010 | 50 | 0.020 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2009 | 7 | 0.020 |
Why?
|
| Theophylline | 1 | 2009 | 30 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2009 | 11 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 48 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 90 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 139 | 0.020 |
Why?
|
| Goats | 1 | 2009 | 60 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 161 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 100 | 0.020 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 25 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 364 | 0.020 |
Why?
|
| Epinephrine | 1 | 2009 | 182 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 773 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2008 | 43 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 318 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 652 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 556 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 66 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2008 | 151 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3752 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 1406 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2008 | 220 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 609 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1332 | 0.020 |
Why?
|
| Infant | 2 | 2014 | 13256 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1041 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 864 | 0.010 |
Why?
|
| Aorta | 1 | 2008 | 562 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 2043 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 7232 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 8636 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 14895 | 0.010 |
Why?
|